Patent expiries ahead, is India Pharma Inc ready?
Beyond the semaglutide momentum, a larger wave of patent expiries is set to…
Interviews
Mumbai Experience Center reflects Agilent’s continued commitment to India
Bharat Bhardwaj, Vice President, Asia Pacific, Agilent Technologies spoke to Viveka Roychowdhury on why Agilent has been…
Industrial and infrastructure sectors are undergoing rapid modernisation
How critical is infrastructure automation in pharma facilities?
Infrastructure is integral to maintaining controlled…
Companies need to look at anti-counterfeiting solutions from the perspective of protecting revenue,…
Can you briefly explain ASPA’s evolution and how the anti‑counterfeiting ecosystem has changed?
ASPA as an organisation started…
